Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-05 4:35 pm Sale |
2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
AMGEN INC AMGN |
1,508,375 4.344% |
-397,323 (-20.85%) |
Filing History |
| 2020-09-10 2:14 pm Purchase |
2020-08-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
3,507,228 10.100% |
1,097,695 (+45.56%) |
Filing History |
| 2020-09-09 5:26 pm Sale |
2020-09-04 | 13D | Akero Therapeutics, Inc. AKRO |
venBio Global Strategic Fund II L.P. | 2,668,717 7.700% |
-653,421 (-19.67%) |
Filing History |
| 2020-07-14 5:06 pm Purchase |
2020-07-10 | 13D | Akero Therapeutics, Inc. AKRO |
ATP Life Science Ventures L.P. | 5,838,869 17.200% |
423,666 (+7.82%) |
Filing History |
| 2020-07-08 3:54 pm Purchase |
2020-07-06 | 13D | Akero Therapeutics, Inc. AKRO |
venBio Global Strategic Fund L.P. | 3,033,552 10.600% |
3,033,552 (New Position) |
Filing History |